NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
Sharp cuts in price of cancer drugs expose excessive pricing, say health experts
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
Previous Post
Next Post
Leave a Reply
Latest News

Stay Connected
Categories
Business Health India Politics Science Sports Technology Uncategorized World
Tags
About the Author

AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed



